Centene Corporation vs UBS Group AG: Strategic Comparison

This in-depth comparison examines Centene Corporation and UBS Group AG across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Centene Corporation on its own, evaluating UBS Group AG, or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Centene Corporation and UBS Group AG is widest.

On the headline numbers, Centene Corporation reports annual revenue of $194.8B against $47.7B for UBS Group AG, while their respective market capitalizations stand at $40.0B and $167.8B. Centene Corporation is headquartered in United States and UBS Group AG operates from Switzerland, and those different home markets shape how each company competes.

Centene Corporation: Centene earns premiums and service revenue by administering government-sponsored healthcare programs, managing provider networks, processing claims, coordinating care, and selling Marketplace and Medicare coverage through subsidiaries and local health plans.

UBS Group AG: UBS is less a traditional bank than a global private-wealth platform with a large Swiss banking base and selective investment banking capabilities. The Credit Suisse acquisition increased scale but made execution the central story.

Centene Corporation and UBS Group AG pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Centene Corporation and UBS Group AG.

Centene Corporation business model: Centene makes money from premiums and service revenue tied to Medicaid managed care, Medicare products, ACA Marketplace plans, commercial products, and specialty services. Profitability depends on rate adequacy, medical cost trends, risk adjustment, contract wins, and regulatory execution.

UBS Group AG business model: UBS makes money from wealth management fees, advisory, lending, Swiss retail and corporate banking, asset management fees, investment banking advisory and capital markets activity, and trading. Wealth management provides the strategic core because asset-based fees recur as long as client assets remain on the platform.

The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Centene Corporation stack up against those of UBS Group AG.

Centene Corporation competitive advantage: Centene's competitive advantage is experience in public-program managed care. Its state-plan footprint, Medicaid expertise, Marketplace reach, local provider networks, and care-management systems give it scale in populations that are operationally complex.

UBS Group AG competitive advantage: UBS's advantage is the combination of Swiss banking trust, global ultra-high-net-worth coverage, more than USD 7 trillion in invested assets, and the ability to serve clients across wealth management, lending, capital markets, and asset management.

Future prospects matter as much as current results. The growth strategies below explain how Centene Corporation and UBS Group AG each plan to expand from here.

Centene Corporation growth strategy: Centene's strategy is to improve performance in core government-sponsored programs, focus on Medicaid and Marketplace execution, manage medical costs, simplify the portfolio, and use scale to compete for state and federal contracts.

UBS Group AG growth strategy: UBS is focused on integrating Credit Suisse, reducing duplicate costs, expanding global wealth management relationships, using technology to improve advisor productivity, growing asset management mandates, and keeping the investment bank focused on capital-light advisory and markets strengths.

A closer look at the financial trajectory of Centene Corporation and UBS Group AG rounds out the comparison.

Centene Corporation: Centene reported $194.777 billion in FY2025 revenue, up from $163.071 billion in FY2024 and $153.999 billion in FY2023. Unlike older profile copy that described a positive FY2025 profit, the latest Form 10-K reports a $6.674 billion net loss attributable to Centene for FY2025. That distinction matters because managed-care revenue can grow while earnings deteriorate. Medical cost trends, Marketplace performance, impairment charges, rate timing, and regulatory exposure can all move profitability even when premium revenue expands.

UBS Group AG: UBS Group reported USD 7.8 billion in 2025 net profit attributable to shareholders and a CET1 ratio of 14.4%. UBS AG consolidated total revenues were USD 47.7 billion, up from USD 42.3 billion in 2024, as Credit Suisse consolidation and client activity reshaped the revenue base.